Nanocarrier-Based Drug Delivery Systems for Remodeling the Melanoma Tumor Microenvironment.
Melanoma remains a major therapeutic challenge in dermatologic oncology because of its aggressive nature and high mortality rate, with traditional therapeutic approaches exhibiting significant limitations in efficacy. Although nanodrug delivery systems (NDS) present a promising paradigm to overcome existing therapeutic...